20172-Bladder Cancer-NA-457

Bladder Cancer

A study of enfortumab vedotin (ASG-22CE) as monotherapy or in combination with other anticancer therapies for the treatment of urothelial cancer (SGN22E-002)

  • Details

ClinicalTrials.gov ID: NCT03288545
Diagnosis Type: NA
USOR Number: 20172

  • Address

3705 West 15th Street
Plano, TX 75075
P: (972) 867-3577

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.